Published December 30, 2018
| Version 1
Other
Open
Evidence-based methodology for identifying drugs with potential human liver toxicities using WHO Vigibase data
- 1. EBTC ar Johns Hopkins Bloomberg School of Public Health
- 2. KEVA Health
- 3. Norwegian Institute of Public Health
Description
Evidence-based methodology for analyzing adverse events related to Drug-Induced Liver Injury (DILI) in WHO Vigibase, a database of Adverse Drug Reactions (ADRs).
Notes
This document is a protocol for analysis of adverse drug reaction reporting Vigibase data, in support of EBTC Tox21 project (evidence stream 3 protocol).
Files
EBTC_Tox 21 Protocol.pdf
Files
(366.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e25b1cc526d9519d6d1d2c483cce2c2f
|
366.1 kB | Preview Download |